Cargando…

Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy

Hereditary ATTR V30M amyloidosis is a lethal autosomal dominant sensorimotor and autonomic neuropathy caused by deposition of aberrant transthyretin (TTR). Immunohistochemical examination of sural nerve biopsies in patients with amyloidotic neuropathy show co-aggregation of TTR with several proteins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fella, Eleni, Sokratous, Kleitos, Papacharalambous, Revekka, Kyriacou, Kyriacos, Phillips, Joy, Sanderson, Sam, Panayiotou, Elena, Kyriakides, Theodoros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423984/ https://www.ncbi.nlm.nih.gov/pubmed/28539873 http://dx.doi.org/10.3389/fnmol.2017.00138

Ejemplares similares

C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy
por: Panayiotou, Elena, et al.
Publicado: (2017)

The role of complement in ATTR amyloidosis: a new therapeutic avenue?
por: Panayiotou, Elena, et al.
Publicado: (2015)

Genetic background modifies amyloidosis in a mouse model of ATTR neuropathy
por: Panayiotou, E., et al.
Publicado: (2016)

C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease
por: Panayiotou, Elena, et al.
Publicado: (2019)

Biomarkers of systemic lupus erythematosus identified using mass spectrometry‐based proteomics: a systematic review
por: Nicolaou, Orthodoxia, et al.
Publicado: (2016)

Alport syndrome: Proteomic analysis identifies early molecular pathway alterations in Col4a3 knock out mice
por: Nicolaou, Orthodoxia, et al.
Publicado: (2020)

Omega-3 fatty acids supplementation protects the retina from age-associated degeneration in aged C57BL/6J mice
por: Prokopiou, Ekatherine, et al.
Publicado: (2019)

Systemic Evaluation of Chimeric LNA/2′-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy
por: Christou, Melina, et al.
Publicado: (2020)

Pharmacological activation of the C5a receptor leads to stimulation of the β-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer’s disease
por: Fella, Eleni, et al.
Publicado: (2022)

Intramuscular Evaluation of Chimeric Locked Nucleic Acid/2′OMethyl-Modified Antisense Oligonucleotides for Targeted Exon 23 Skipping in Mdx Mice
por: Georgiadou, Michaella, et al.
Publicado: (2021)

Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
por: Cruz, Márcia Waddington
Publicado: (2019)

ProtExA: A tool for post-processing proteomics data providing differential expression metrics, co-expression networks and functional analytics
por: Minadakis, George, et al.
Publicado: (2020)

Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy
por: Gendre, Thierry, et al.
Publicado: (2019)

Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy
por: Dardiotis, Efthimios, et al.
Publicado: (2023)

Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015)

Imaging cardiac ATTR amyloid
por: Hawkins, Philip N
Publicado: (2015)

Preliminary assessment of neuropathy progression in patients with hereditary ATTR amyloidosis after orthotopic liver transplantation (OLT)
por: Adams, David, et al.
Publicado: (2015)

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
por: Klaassen, Sebastiaan, et al.
Publicado: (2015)

Guidelines for genetic counselling in ATTR amyloidosis
por: Sequeiros, Jorge
Publicado: (2015)

Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015)

ATTR Epidemiology, Genetics, and Prognostic Factors
por: Obi, Chukwuemeka A., et al.
Publicado: (2022)

Diagnosis and Treatment of AL and ATTR Amyloidosis
por: Faiman, Beth, et al.
Publicado: (2021)

An unusual case of suprascapular nerve neuropathy: a case report
por: Economides, Charalambos P, et al.
Publicado: (2011)

Attred: Attribute Based Resource Discovery for IoT †
por: Kamel, Mohammed B. M., et al.
Publicado: (2021)

Intestinal Metabolites Influence Macrophage Phagocytosis and Clearance of Bacterial Infection
por: O’Callaghan, Amy A., et al.
Publicado: (2021)

High-Throughput Native Mass Spectrometry Screening in Drug Discovery
por: Gavriilidou, Agni F. M., et al.
Publicado: (2022)

Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups
por: Rintell, David, et al.
Publicado: (2021)

Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis
por: Nicolaou, Orthodoxia, et al.
Publicado: (2020)

Transcriptional signature in microglia associated with Aβ plaque phagocytosis
por: Grubman, Alexandra, et al.
Publicado: (2021)

Retiring LevelDBs with the new FST attr backend
por: Lekshmanan, Abhishek
Publicado: (2023)

Glavonoid, a possible supplement for prevention of ATTR amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2021)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

Conventional heart failure therapy in cardiac ATTR amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Systems Bioinformatics: increasing precision of computational diagnostics and therapeutics through network-based approaches
por: Oulas, Anastasis, et al.
Publicado: (2017)

Phagocytosis is a primary determinant of pulmonary clearance of clinical Klebsiella pneumoniae isolates
por: van der Geest, Rick, et al.
Publicado: (2023)

Extensor plaques with associated arthritis and neuropathy
por: Gioe, Olivia A., et al.
Publicado: (2020)

Polyarthritis, neuropathy, and persistent violaceous plaques
por: Ladenheim, Alexander, et al.
Publicado: (2021)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
por: Lobato, Luisa
Publicado: (2015)

TUDCA as an autophagic modulator of ATTR V30M Amyloidosis
por: Teixeira, Cristina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v5qcflfn37idu5v23hueq68s1h